BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mroginski Weber D, Voss GT, de Oliveira RL, da Fonseca CA, Paltian J, Rodrigues K, Rodrigues Ianiski F, Vaucher R, Luchese C, Antunes Wilhelm E. Topic application of meloxicam-loaded polymeric nanocapsules as a technological alternative for treatment of the atopic dermatitis in mice. J Appl Biomed 2018;16:337-43. [DOI: 10.1016/j.jab.2018.03.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ramos Campos EV, Proença PLF, Doretto-Silva L, Andrade-Oliveira V, Fraceto LF, de Araujo DR. Trends in nanoformulations for atopic dermatitis treatment. Expert Opin Drug Deliv 2020;17:1615-30. [PMID: 32816566 DOI: 10.1080/17425247.2020.1813107] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
2 Voss GT, de Oliveira RL, Davies MJ, Domingues WB, Campos VF, Soares MP, Luchese C, Schiesser CH, Wilhelm EA. Suppressive effect of 1,4-anhydro-4-seleno-D-talitol (SeTal) on atopic dermatitis-like skin lesions in mice through regulation of inflammatory mediators. J Trace Elem Med Biol 2021;67:126795. [PMID: 34091240 DOI: 10.1016/j.jtemb.2021.126795] [Reference Citation Analysis]
3 Hemrajani C, Negi P, Parashar A, Gupta G, Jha NK, Singh SK, Chellappan DK, Dua K. Overcoming drug delivery barriers and challenges in topical therapy of atopic dermatitis: A nanotechnological perspective. Biomed Pharmacother 2022;147:112633. [PMID: 35030434 DOI: 10.1016/j.biopha.2022.112633] [Reference Citation Analysis]